New weight loss shot shows promise in early human testing
NCT ID NCT06640647
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single dose of an investigational drug called HDM1005 in 65 healthy adults who were overweight or had obesity. The main goal was to check if the injection is safe and how the body processes it. Researchers also looked at changes in weight and other health markers. The study is complete, but results are not yet public.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home visits may boost heart health for pregnant women in nigeria
- Could a diabetes drug protect obese Teens' hearts?
- Could a biweekly shot rival weekly Weight-Loss drugs?
- Scientists investigate why some bodies fight weight change
- Fasting test may unlock personalized obesity treatment
- Ancient herbs take on obesity and joint pain: a new clinical trial